Purpose To evaluate polyalkylimide as a possible vitreous tamponading agent. Methods A 20-gauge pars plana vitrectomy and posterior vitreous detachment were performed in the right eye of six pigmented rabbits. Approximately 1 ml of viscoelastic gel, polyalkylimide (Bio-Alcamid®) was thereafter injected into the vitreous space. Full-field ERG and intraocular pressure (IOP, Tonopen) was measured pre-and postoperatively at regular intervals up to 28 days. At day 6 or 28, the rabbits were sacrificed and the eyes were examined macroscopically, photographed, and prepared for histological examination with routine microscopy. Results The viscoelastic hydrogel was successfully injected, and remained translucent with preserved gel properties throughout the postoperative period. The postoperative IOP was unchanged compared to preoperative values. Five of six eyes displayed retinal edema or pigmentary changes centrally while the periphery appeared intact. ERG recordings showed a radical decrease in rod-and cone-derived B-wave amplitudes. Histological examination confirmed varying degrees of edema combined with neuronal cell death within the retinal layers in the central part of the fundus, while the peripheral part appeared intact.
Introduction
Several eye disorders such as rhegmatogenous retinal detachment, severe diabetic retinopathy, and penetrating trauma affect the retina to such an extent that surgical removal of the vitreous and replacement with a tamponading agent is often necessary. The pars plana vitrectomy paradigm in such cases includes vitreous removal and replacement with saline solution or tamponades in the form of air, perfluorocarbon liquids, intraocular expanding gas or silicone oil. However, current clinical tamponading agents are all associated with complications. Gas and silicone oil disturb the normal optical properties of the eye, induce cataract and IOP elevation, and demand awkward posturing regimes. In addition, the tamponading effect of gas is limited in time, while oil and perfluorocarbon liquids require a second procedure for removal [1, 2] . Finding novel long-term tamponading agents with less adverse effects is thus a justified challenge.
The ideal vitreous tamponading agent requires surface properties restricting inflow of water through existing breaks, and interfacial tension preventing the tamponade itself to enter these breaks. However, several other factors also need to be considered, such as optical clarity, refractive index, long-term molecular stability, biological atoxicity, and molecular transport.
Chemically different compounds such as hyaluronic acid (Healon®), perfluorinated organic liquids and various synthetic polymers have been tested in the laboratory ( [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] ). So far, their potential use has been limited due to degradation problems, opacification, retinotoxicity and IOP elevation.
A fairly recent idea is to explore substances used successfully in other surgical areas [13] . One potential compound is the acrylamide derivative Bio-Alcamid® (polyalkylimide), a clear hydrogel used as subcutaneous filler in reconstructive plastic surgery [14] . Bio-Alcamid® has been found to be highly bio-compatible, chemically and physically stable. Interestingly, from a vitreous tamponading point of view, this compound has also been demonstrated to form a thin collagen capsule isolating it from the host tissue. These attributes, together with the possibility of uncomplicated removal, make Bio-Alcamid® a theoretically attractive option for intravitreal use.
In the present paper, we present an experimental protocol involving vitrectomy, retinal morphology and function to test the feasability of Bio-Alcamid® as a vitreous tamponade.
Material and methods
The study was approved by The Regional Ethics Committee for Animal Experiments in Lund, and it also conformed to the ARVO Resolution on the Use of Animals in Vision and Ophthalmic Research.
Six pigmented rabbits, aged 4 months were used in the experiment. The right eye was operated upon and filled with Bio-Alcamid®, while the left eye served as control. Additional two rabbits were vitrectomized in their right eyes and filled with BSS®. They served as controls to the surgical procedure.
Examination including ophthalmoscopy and IOP measurement (Tonopen) was performed at postoperative days 1, 6 and 28. The rabbits were sacrificed at day 6 (n=1) or 28 (n=5), at which time the eyes were gross examined, photographed and prepared for histological examination with routine microscopy.
Gel properties
Bio-Alcamid® (Polymekon, Brindisi, Italy) is a gel polymer comprised exclusively of networks of alkylimide groups (approximately 4%) and non-pyrogenic water (approximately 96%). Alkylimide belongs to the family of acryl derivatives, and its polymeric structure does not contain free monomers. The gel is available on the market, and used clinically in plastic surgery as non-degradable filler in aesthetic lipoathrophic conditions and after posttraumatic or therapeutic atrophy of subcutaneous tissue. ( [15] ; [14] ; [16] ). When placed in the subcutaneous space, the gel forms a thin collagen capsule, and it is extractable even after several years without signs of degrading.
Surgery
All procedures were performed by clinically wellexperienced vitreoretinal surgeons. General anesthesia was provided with a combination of ketamine (35 mg/kg) and xylazine (5 mg/kg) intramuscularly. The right eye was instilled with cyclopentolate (1%) and phenylephrine (10%) 30 minutes before surgery. Topical tetracaine (0.5%) was applied just before surgery. The conjunctiva was incised limbally 270°from 9 to 6 o'clock with a vertical incision at 12 o'clock, creating two flaps. A 20 G infusion cannula was sutured to the sclera in the 4 o'clock position 1 mm posterior to the limbus, and a balanced salt solution (BSS, Endosol, Allergan Medical Optics) was started. Two 20 G sclerotomies were made in the 10 and 2 o'clock positions. A BIOM 90-D lens (Oculus) was used to visualize the fundus, and an Accurus surgical system machine (Alcon, Fort Worth, TX, USA) was used for surgery. A standard endo-illuminating light probe (Alcon) was introduced through the 10 o'clock sclerotomy (illumination level 80%), and a vitreous cutter (Innovit, Alcon) was inserted through the 2 o'clock sclerotomy. Posterior vitreous detachment (PVD) was created by positioning the vitrectomy probe at the margin of the disk and applying suction (100 mmHg) while pulling on the probe. PVD was confirmed visually as the posterior vitreous cortex separated from the posterior pole. All vitreous in the central fundus (approximately 50% of the total volume) was removed, while peripheral parts were left because of the risk of instrument touch on the comparatively large lens. In two cases, pin-point hemorrhages appeared at the central retina after PVD induction, and in one case a retinal touch with the vitrector occurred, causing a minimal retinal hemorrhage. The hemorrhage stopped quickly, and the touch did not lead to any retinal break or detachment in the postoperative period. After vitreous removal, a fluid-air exchange was performed, after which Bio-Alcamid® was injected under visual control through a 19-gauge needle. The amount of gel injected varied from 0.4 to 1.2 ml ( Table 1) . The sclerotomies and conjunctiva were sutured, and 25 mg gentamicin and 2 mg betamethasone were injected subconjunctivally. No postoperative treatment was given. The eyes were examined externally daily, and with an external ophthalmoscope at days 1 and 10. Two eyes, used as controls, underwent the above surgery, but were injected with balanced salt solution (BSS®) instead of Bio-Alcamid®. These two animals were followed for 41 days.
Full-field ERG
A standardized full-field electroretinography (ERG) was recorded 7 days before surgery and 28 days postoperatively on the right eye, using a Nicolet Viking analysis system (Nicolet Biomedical Instruments, Madison, WI, USA) as previously described [17] . During examination, the rabbits were sedated with Hypnorm®, (fentanyl 0.2 mg/ml and fluanisone 10 mg/ml) 0.1 ml/kg intramuscularly, and the pupils were dilated with Cyclogyl® (cyclopentolate hydrochloride 1%) to a pupil diameter of 8-9 mm.
After 30 minutes of dark adaptation, a Burian-Allen bipolar ERG contact lens electrode was applied on the topically anesthetized cornea, together with a subcutaneous ground electrode on the neck. The lens was lubricated with methylcellulose (2%). Responses were obtained with a wide-band filter (−3dB at 1 Hz and 500 Hz), stimulating with single full-field flashes (30 μs) with dim blue light (Wratten filters # 47, 47A and 47B) and of white light (0.8cd.s/m2) without a background, and of white light Tissue preparation At day 6 or 28, the rabbits were sacrificed and the eyes were dissected, gross examined and fixed for 1 h in 4% formalin, pH 7.3 in a 0.1 M Sørensen's phosphate buffer (PB). After fixation, the specimens were washed with 0.1 M Sørensen's PB, and then washed again using the same solution containing sucrose of rising concentrations (5-25%). The specimens were sectioned at 12 μm on a cryostat, and each 10th slide was stained with hematoxylin and eosin according to standard procedures.
For glial fibrillary acidic protein (GFAP) immunolabeling, sections were washed in 0.1 M of sodium phosphate-buffered saline pH 7.2 (PBS) with 0.1% Triton X-100 (PBS/Triton), and incubated with the primary antibody (anti-GFAP, clone G-A-5; Millipore, Sundbyberg, Sweden, diluted 
Results

Macroscopic findings
No adverse conjunctival swelling or inflammation of any eye injected with polyalkylimide hydrogel was observed postoperatively. Postoperative IOP (9-15 mmHg) was unchanged compared with preop values (8-13 mmHg). On postoperative day 1, moderate lens opacities were noted in four eyes, making fundus examination difficult. In one eye, the retina appeared normal, and in the remaining one, a limited retinal detachment was seen. On postoperative day 6, all eyes displayed posterior cataract, with fundus visualization possible in four eyes (Fig. 1a) . At this time, one eye (#5) displayed profound choroidal swelling with spot hemorrhages on the retina, and this animal was therefore terminated (Fig. 1b) . At dissection, this eye was found to be well-filled with the hydrogel, which remained clear but displayed a substantial degree of fragmentation (Fig. 2a) . The remaining eyes were kept until postoperative day 28, at which time some extent of lens opacification was still present in four out of five cases, but fundus visualization was possible in all eyes. One eye displayed total retinal detachment, three eyes had pigmentations in the posterior fundus, and the remaining one appeared normal. No signs of proliferative vitreoretinopathy (PVR) were seen. The translucent gel filled the vitreous space in four eyes, and was well-apposed to the retinal surface ( Fig. 2b and c) . In three eyes, some degree of fragmentation of the gel was noted. In the eye with retinal detachment, the gel could not be identified. The BSS® injected eyes displayed no cataract, clear vitreous and intact retina.
Histology
In the eye terminated on postoperative day 6, light microscopy using hematoxylin and eosin staining revealed neuroretinal destruction of all retinal layers and RPE within the central part of the fundus, while the peripheral part appeared intact (Fig. 3a-c) . The choroidal space in this eye was enlarged, without any normal vessels. No signs of inflammation were seen.
In eyes terminated at day 28, varying degrees of neuroretinal degeneration was seen. In one eye, the retina appeared normal, three eyes displayed neuroretinal degeneration centrally with profound changes in the inner retinal layers, and in the eye with retinal detachment, total neuroretinal destruction was seen. In most eyes, a sharp demarcation was seen between degenerated and more normal retina, indicating a variation of locations of the neuroretina cellular destruction (Fig. 3d) . Two eyes displayed invasion of leucocytes in the subretinal space (Fig. 3e) . No other signs of inflammation were seen. In the areas of retinal degeneration, disruption of RPE cells was evident; in areas of more normal retina, the RPE also appeared normal. No enlargement of the choroidal space was seen in these specimens.
The two BSS-injected eyes displayed normal retinal morphology.
GFAP immunolabeling
All Bio-Alcamid®-injected eyes displayed upregulation of GFAP as a sign of Müller cell activation.No particular difference in labeling intensity was found between central and peripheral retina, but in degenerated parts, Müller cells were not arranged in the normal vertical manner (Fig. 4) . In BSS-injected eyes, GFAP labeling was comparable with normal unoperated controls, with discrete labeling of Müller cells seen only in the periphery.
ERG
Full-field ERG measurements were obtained pre-and postoperatively in five eyes (one rabbit was sacrificed after Table 2 ). These recordings demonstrated a reduction of both cone and rod b-wave amplitudes 28 days postoperatively compared with preoperative values in four cases (Fig. 5) . In the eye with detachment (#1), no residual response could be measured, while in the remaining four, varying degrees of functions was still present.
Discussion
Attempts to develop new vitreous tamponading agents have been ongoing for several decades. Various substances and approaches have been explored, but to date clinically available alternatives to conventional tamponades are still very limited [4, [18] [19] [20] . To identify and develop a novel agent is a challenging task, albeit with a large therapeutical potential. The various conditions in which a synthetic long-term tamponade could be used may demand different properties, but all require compound-to-retina contact preventing water inflow through existing breaks.
In the present study we have evaluated Bio-Alcamid® as a vitreal tamponade, using a previously described protocol involving vitrectomy with postoperative evaluation of retinal morphology as well as function [21] . We found that the viscoelastic polyalkylimide hydrogel developed for reconstructive surgery can be injected in the vitreous space in the normal rabbit eye. The gel remained clear with retained viscosity for at least 28 days, factors that are important when considering its use as a tamponading agent. In contrast to previous reports in reconstructive surgery, a surrounding capsule was not found; instead, the gel displayed uninterrupted apposition with the retinal surface without signs of PVR.
When the natural vitreous is removed, a new metabolic and physiologic environment is created within the eye. Specifically, oxygen concentration, osmotic balance and molecular transport in the vitreous space are altered in a manner that may affect all interior tissues of the eye [22] . In this setting, the rabbit retina may be especially vulnerable to biochemical changes due to its merangiotic nature (partly vascularized, i.e., the retinal layers are dependent on nutritive supply from the choroid and also the vitreous [23] ). It has been demonstrated that the oxygen concentration changes from 15 to 80% in the vitreous space after vitrectomy [22] . This phenomenon has also been shown in rabbits by Barbazetto et al. [24] . The normal PO 2 gradient from the lens to the retina disappears after vitrectomy, and the oxygen concentration near the lens increases 2-3 times. In humans, the increased oxygen concentration close to the crystalline lens has been implicated in cataract formation postvitrectomy [25] . We observed pathological changes in Bio-Alcamid®-filled eyes early in the postoperative period, not only in the retina, but also in the lens. We detected no such changes in BSS-injected eyes, indicating that the polyalkylimide gel and not the surgical procedure is responsible for pathological changes. Due to the relatively large size of the lens, PVD and vitrectomy is only possible in the central part of the rabbit eye, which in turn prevents a complete fill of the gel. Degenerative retinal changes were seen almost exclusively in central parts of the retina and not in the periphery, where the natural vitreous remained, suggesting that direct gel-to-retina contact is responsible for the adverse influence on the retina. The amount of removed vitreous, and as a consequence, the space that could be filled with gel varied between 0.4-1.0 ml, which was probably attributable to variations in lens size and volume of the rabbit eye [26] . Interestingly, the eye which was filled with the largest volume of hydrogel (#1, 1.0 ml) displayed the most profound pathological changes while the eye with only 0.4 ml (#3) of gel had only minimal changes. BioAlcamide® contains polyalkylimide which belongs to the family of acryl derivatives. In monomeric form, some members of the acryl derivatives are well-known to produce neurotoxicity characterized by neuronal swelling [27] . The polyalkylimide macromolecular gel is formed by crosslinking of amide-imide alkyl-type molecules. This gel has been found to be atoxic when applied on the skin or on cultured fibroblast, but to induce swelling and hyperemia after subcutaneous injection in the rat [28] . In the present work, we noted abnormal retinal edema early in the postoperative period, and we can therefore not rule out the possibility of a direct toxic effect of the compound. To sum up, intravitreal polyalkylimide gel induces severe retinal pathological reactions within the rabbit eye, but displays physical properties which fulfill several of the requirements of an ideal vitreous tamponade. Future work will now be focused on eliminating toxic influence without altering the gel structure.
